# Stellate Ganglion Block

> **NCT06271707** · PHASE4 · RECRUITING · sponsor: **University of Minnesota** · enrollment: 48 (estimated)

## Conditions studied

- Esophagectomy
- Pneumonectomy
- Lobectomy

## Interventions

- **DRUG:** 0.5% bupivacaine
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT06271707
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-19
- **Primary completion:** 2027-04-15
- **Final completion:** 2027-07-15
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06271707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06271707, "Stellate Ganglion Block". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06271707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*